Amalgamated Financial’s Boston Scientific BSX Stock Holding History

Amalgamated Financial’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$15.8M	Buy	+357,726	New	+$15.5M	0.13%	130

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Amalgamated Financial's BSX Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Boston Scientific (BSX) in Q1 2022: 357,726 shares worth $15.8M. The stake represents 0.13% of the portfolio and ranks #130 among its holdings.

905 funds tracked by Wall St. Rank hold BSX as of Q1 2022.

Amalgamated Financial held 357,726 shares of Boston Scientific worth $15.8M as of Q1 2022.
Boston Scientific was a new Amalgamated Financial position in Q1 2022.
Boston Scientific made up 0.13% of Amalgamated Financial's portfolio in Q1 2022, its #130 holding.
905 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.